These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19453903)

  • 41. Potential risks of chronic sildenafil use for priapism in sickle cell disease.
    Lane A; Deveras R
    J Sex Med; 2011 Nov; 8(11):3193-5. PubMed ID: 21883942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Idiopathic stuttering priapism: recovery of detumescence mechanism with temporal use of antiandrogen.
    Yamashita N; Hisasue S; Kato R; Masumori N; Takahashi A; Itoh N; Tsukamoto T
    Urology; 2004 Jun; 63(6):1182-4. PubMed ID: 15183981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Priapism caused by 'All Nite Long'.
    Miocinovic R; Zafar S; Sferra J; Wainstein M
    Int J Impot Res; 2005; 17(5):469-70. PubMed ID: 15944727
    [No Abstract]   [Full Text] [Related]  

  • 44. εGγAγδβ0-thalassemia: a rare but clinically significant cause of hemolytic anemia in infants.
    Audino AN; Yeager ND
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):e49-50. PubMed ID: 23128329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: report of an international randomized control trial--the priapism in sickle cell study.
    Olujohungbe AB; Adeyoju A; Yardumian A; Akinyanju O; Morris J; Westerdale N; Akenova Y; Kehinde MO; Anie K; Howard J; Brooks A; Davis VA; Khoriatry AI
    J Androl; 2011; 32(4):375-82. PubMed ID: 21127308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The hypercoagulable state in thalassemia intermedia.
    Taher AT; Musallam KM; Inati A
    Hemoglobin; 2009; 33 Suppl 1():S160-9. PubMed ID: 20001621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New insights into the pathophysiology of sickle cell disease-associated priapism.
    Bivalacqua TJ; Musicki B; Kutlu O; Burnett AL
    J Sex Med; 2012 Jan; 9(1):79-87. PubMed ID: 21554553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of recurrent priapism with epinephrine self-injection and gonadotropin-releasing hormone analogue.
    Steinberg J; Eyre RC
    J Urol; 1995 Jan; 153(1):152-3. PubMed ID: 7966754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular mechanisms underlying thalassemia intermedia in Iran.
    Neishabury M; Azarkeivan A; Oberkanins C; Esteghamat F; Amirizadeh N; Najmabadi H
    Genet Test; 2008 Dec; 12(4):549-56. PubMed ID: 18939939
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extramedullary hematopoiesis with spinal cord compression in a child with thalassemia intermedia.
    Ileri T; Azik F; Ertem M; Uysal Z; Gozdasoglu S
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):681-3. PubMed ID: 19687759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tadalafil-associated priapism.
    King SH; Hallock M; Strote J; Wessells H
    Urology; 2005 Aug; 66(2):432. PubMed ID: 16051318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination of vacuum erection device and PDE5 inhibitors as salvage therapy in PDE5 inhibitor nonresponders with erectile dysfunction.
    Canguven O; Bailen J; Fredriksson W; Bock D; Burnett AL
    J Sex Med; 2009 Sep; 6(9):2561-7. PubMed ID: 19627462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thalassemia intermedia: revisited.
    Taher A; Isma'eel H; Cappellini MD
    Blood Cells Mol Dis; 2006; 37(1):12-20. PubMed ID: 16737833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Priapism in sickle cell disease.
    Rogers ZR
    Hematol Oncol Clin North Am; 2005 Oct; 19(5):917-28, viii. PubMed ID: 16214652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics, behaviors, and attitudes of men bypassing the healthcare system when obtaining phosphodiesterase type 5 inhibitors.
    Schnetzler G; Banks I; Kirby M; Zou KH; Symonds T
    J Sex Med; 2010 Mar; 7(3):1237-46. PubMed ID: 20136707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intracavernosal etilefrine self-injection therapy for recurrent priapism: one decade of follow-up.
    Teloken C; Ribeiro EP; Chammas M; Teloken PE; Souto CA
    Urology; 2005 May; 65(5):1002. PubMed ID: 15882751
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Splenectomy in hereditary hemolytic anemia: 82 Tunisian cases].
    Hafsia R; Zriba S; Gouider E; Ben Salah N; Borji W; Zaouche A
    Tunis Med; 2009 May; 87(5):323-7. PubMed ID: 19927762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myelofibrosis: a cause of increased transfusion requirement in a child with β-thalassemia intermedia.
    Nirupam N; Maheshwari A; Rath B; Chandra J; Kumar P; Basu S; Nangia A
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):143-5. PubMed ID: 22009011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Idiopathic priapism in a young boy.
    Jensen JL; Lund L
    Scand J Urol Nephrol; 2003; 37(1):83-4. PubMed ID: 12745751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment with hydroxyurea in thalassemia intermedia with paravertebral pseudotumors of extramedullary hematopoiesis.
    Cario H; Wegener M; Debatin KM; Kohne E
    Ann Hematol; 2002 Aug; 81(8):478-82. PubMed ID: 12224008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.